COVID-19

COVID-19: What you need to know about the coronavirus pandemic on 3 February

A healthcare worker is pictured at a swabbing station during the coronavirus disease (COVID-19) outbreak in Singapore January 25, 2021. REUTERS/Edgar Su     TPX IMAGES OF THE DAY - RC21FL9HDCBY

COVID-19 cases continue to rise globally. Image: REUTERS/Edgar Su

Joe Myers
Writer, Forum Agenda
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on COVID-19?
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

Listen to the article

  • This daily round-up brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and tools to help you stay informed and protected.
  • Top stories: Eurozone economy contracts less than expected in Q4; Russia's Sputnik V vaccine 92% effective; 2 million Australians enter lockdown.
Have you read?

1. How COVID-19 is affecting the globe

Confirmed cases of COVID-19 have now passed 103.8 million globally, according to the Johns Hopkins Coronavirus Resource Center. The number of confirmed deaths stands at more than 2.25 million.

Japan's services sector shrank at the fastest pace in five months in January. It was hit by a resurgence in COVID-19 cases and a state of emergency in parts of the country.

The Eurozone economy contracted less than expected in the fourth quarter of 2020, according to initial EU estimates. But it's heading for another, probably steeper, decline in the first quarter of this year.

Germany will have vaccinated 10 million people by the end of March, Chancellor Angela Merkel told ARD television yesterday.

Dutch Prime Minister Mark Rutte says that most lockdown measures – many of which have been in place since October – will remain in place for weeks yet.

Captain Sir Tom Moore, who raised millions for Britain's National Health Service by walking laps of his garden, has died aged 100 with COVID-19.

Discover

What is the Global Alliance for Social Entrepreneurship?

2. Russia's Sputnik V vaccine 92% effective

Scientists have given Russia's Sputnik V vaccine the green light. It's almost 92% effective in fighting COVID-19, according to peer-reviewed late-stage trial results published in The Lancet.

Russia approved the vaccine in August, before the large-scale trial had begun.

“The development of the Sputnik V vaccine has been criticised for unseemly haste, corner cutting, and an absence of transparency,” said Ian Jones, professor at the University of Reading, and Polly Roy, professor at the London School of Hygiene & Tropical Medicine.

“But the outcome reported here is clear and the scientific principle of vaccination is demonstrated,” the scientists, who were not involved in the study, said in a comment shared by The Lancet. “Another vaccine can now join the fight to reduce the incidence of COVID-19.”

Loading...

2. Two million Australians enter lockdown

A five-day lockdown is in progress in Perth, capital of Western Australia, after the discovery of one case in the community.

Authorities ordered a full lockdown after a security guard at a hotel used to quarantine people returning from overseas was found to have to contracted the virus. Authorities also moved to test and isolate close contacts of the guard.

“In total 13 close contacts have now tested negative and of those 11 high-risk contacts have been moved into hotel quarantine as an extra precaution,” Western Australia state Premier Mark McGowan told reporters in Perth.

Australia has limited cases to less than 29,000 and deaths to less than 1,000 through measures like this and strict border controls.

Cumulative confirmed COVID-19 cases in Australia
Australia has kept total case numbers relatively low. Image: Our World in Data
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Global Health
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Winding down COVAX – lessons learnt from delivering 2 billion COVID-19 vaccinations to lower-income countries

Charlotte Edmond

January 8, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum